Kiromic BioPharma, Inc. (KRBP) Financials

KRBP Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 14.2 million 18.7 million
June 30, 2023 13.6 million 19.9 million
March 31, 2023 12.0 million 17.7 million
Dec. 31, 2022 12.0 million 17.7 million

KRBP Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -5.3 million 26400
June 30, 2023 -6.5 million 35400
March 31, 2023 -4.2 million 609600
Dec. 31, 2022 -4.2 million 609600

KRBP Net Income

No data available :(

KRBP Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 4.4 million - 1.7 million
June 30, 2023 2.7 million - 1.8 million
March 31, 2023 645200 - 2.0 million
Dec. 31, 2022 - - 2.1 million

KRBP Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 1.2 million
June 30, 2023 1.1 million
March 31, 2023 544529
Dec. 31, 2022 683490

KRBP Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 97500 2.7 million 2.9 million -
June 30, 2023 - 2.0 million 2.3 million -
March 31, 2023 57200 3.3 million 3.6 million -
Dec. 31, 2022 57200 3.3 million 3.6 million -

KRBP Cost of Revenue

No data available :(

KRBP

Price: $0.08

52 week price:
0.05
3.32

Earnings Per Share: -3.17 USD

P/E Ratio: -0.04

Exchange: OQB

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.8 million

Market Capitalization: 318418

Links: